500 related articles for article (PubMed ID: 33559845)
1. Gut Microbiome and Precision Nutrition in Heart Failure: Hype or Hope?
Chaikijurajai T; Tang WHW
Curr Heart Fail Rep; 2021 Apr; 18(2):23-32. PubMed ID: 33559845
[TBL] [Abstract][Full Text] [Related]
2. Gut microbiome - A potential mediator of pathogenesis in heart failure and its comorbidities: State-of-the-art review.
Mamic P; Chaikijurajai T; Tang WHW
J Mol Cell Cardiol; 2021 Mar; 152():105-117. PubMed ID: 33307092
[TBL] [Abstract][Full Text] [Related]
3. Exploring the Microbiome in Heart Failure.
Kitai T; Kirsop J; Tang WH
Curr Heart Fail Rep; 2016 Apr; 13(2):103-9. PubMed ID: 26886380
[TBL] [Abstract][Full Text] [Related]
4. The heart and gut relationship: a systematic review of the evaluation of the microbiome and trimethylamine-N-oxide (TMAO) in heart failure.
Anderson KM; Ferranti EP; Alagha EC; Mykityshyn E; French CE; Reilly CM
Heart Fail Rev; 2022 Nov; 27(6):2223-2249. PubMed ID: 35726110
[TBL] [Abstract][Full Text] [Related]
5. Microbial metabolites and heart failure: Friends or enemies?
Lu X; Liu J; Zhou B; Wang S; Liu Z; Mei F; Luo J; Cui Y
Front Microbiol; 2022; 13():956516. PubMed ID: 36046023
[TBL] [Abstract][Full Text] [Related]
6. Intersections Between Microbiome and Heart Failure: Revisiting the Gut Hypothesis.
Nagatomo Y; Tang WH
J Card Fail; 2015 Dec; 21(12):973-80. PubMed ID: 26435097
[TBL] [Abstract][Full Text] [Related]
7. Role of the intestinal microbiome and its therapeutic intervention in cardiovascular disorder.
Luqman A; Hassan A; Ullah M; Naseem S; Ullah M; Zhang L; Din AU; Ullah K; Ahmad W; Wang G
Front Immunol; 2024; 15():1321395. PubMed ID: 38343539
[TBL] [Abstract][Full Text] [Related]
8. Metagenomic analysis of gut microbiota reveals its role in trimethylamine metabolism in heart failure.
Emoto T; Hayashi T; Tabata T; Yamashita T; Watanabe H; Takahashi T; Gotoh Y; Kami K; Yoshida N; Saito Y; Tanaka H; Matsumoto K; Hayashi T; Yamada T; Hirata KI
Int J Cardiol; 2021 Sep; 338():138-142. PubMed ID: 34102245
[TBL] [Abstract][Full Text] [Related]
9. TMAO: how gut microbiota contributes to heart failure.
Zhang Y; Wang Y; Ke B; Du J
Transl Res; 2021 Feb; 228():109-125. PubMed ID: 32841736
[TBL] [Abstract][Full Text] [Related]
10. Changes of gut microbiome composition and metabolites associated with hypertensive heart failure rats.
Li L; Zhong SJ; Hu SY; Cheng B; Qiu H; Hu ZX
BMC Microbiol; 2021 May; 21(1):141. PubMed ID: 33952214
[TBL] [Abstract][Full Text] [Related]
11. Heart Failure: a Punch from the Gut.
Mahenthiran A; Wilcox J; Tang WHW
Curr Heart Fail Rep; 2024 Apr; 21(2):73-80. PubMed ID: 38300390
[TBL] [Abstract][Full Text] [Related]
12. Current understanding of gut microbiota alterations and related therapeutic intervention strategies in heart failure.
Chen X; Li HY; Hu XM; Zhang Y; Zhang SY
Chin Med J (Engl); 2019 Aug; 132(15):1843-1855. PubMed ID: 31306229
[TBL] [Abstract][Full Text] [Related]
13. Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure.
Trøseid M; Ueland T; Hov JR; Svardal A; Gregersen I; Dahl CP; Aakhus S; Gude E; Bjørndal B; Halvorsen B; Karlsen TH; Aukrust P; Gullestad L; Berge RK; Yndestad A
J Intern Med; 2015 Jun; 277(6):717-26. PubMed ID: 25382824
[TBL] [Abstract][Full Text] [Related]
14. The Gut Axis Involvement in Heart Failure: Focus on Trimethylamine N-oxide.
Salzano A; Cassambai S; Yazaki Y; Israr MZ; Bernieh D; Wong M; Suzuki T
Heart Fail Clin; 2020 Jan; 16(1):23-31. PubMed ID: 31735312
[TBL] [Abstract][Full Text] [Related]
15. The gut microbiome and heart failure: A better gut for a better heart.
Branchereau M; Burcelin R; Heymes C
Rev Endocr Metab Disord; 2019 Dec; 20(4):407-414. PubMed ID: 31705258
[TBL] [Abstract][Full Text] [Related]
16. Gut Microbiota Composition and Cardiovascular Disease: A Potential New Therapeutic Target?
Belli M; Barone L; Longo S; Prandi FR; Lecis D; Mollace R; Margonato D; Muscoli S; Sergi D; Federici M; Barillà F
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569352
[TBL] [Abstract][Full Text] [Related]
17. Gut microbiome and metabolites, the future direction of diagnosis and treatment of atherosclerosis?
Cao H; Zhu Y; Hu G; Zhang Q; Zheng L
Pharmacol Res; 2023 Jan; 187():106586. PubMed ID: 36460280
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol Attenuates Trimethylamine-N-Oxide (TMAO)-Induced Atherosclerosis by Regulating TMAO Synthesis and Bile Acid Metabolism via Remodeling of the Gut Microbiota.
Chen ML; Yi L; Zhang Y; Zhou X; Ran L; Yang J; Zhu JD; Zhang QY; Mi MT
mBio; 2016 Apr; 7(2):e02210-15. PubMed ID: 27048804
[TBL] [Abstract][Full Text] [Related]
19. Metabolites Linking the Gut Microbiome with Risk for Type 2 Diabetes.
Zhu T; Goodarzi MO
Curr Nutr Rep; 2020 Jun; 9(2):83-93. PubMed ID: 32157661
[TBL] [Abstract][Full Text] [Related]
20. Insights into the associations between the gut microbiome, its metabolites, and heart failure.
Ahmad AF; Caparrós-Martin JA; Gray N; Lodge S; Wist J; Lee S; O'Gara F; Shah A; Ward NC; Dwivedi G
Am J Physiol Heart Circ Physiol; 2023 Dec; 325(6):H1325-H1336. PubMed ID: 37737730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
